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Abstract
Extra-corporeal membrane oxygenation (ECMO) is a rapidly evolving therapy 
for acute lung and/or heart failure. ECMO, from a technical standpoint, is con-
ceptually simple—however, it can be very challenging to implement therapy at the 
individual patient level as well as at hospital (or healthcare system) level. ECMO 
program development involves engagement of key stake-holders including physi-
cians, nursing, and administrative leadership. The goal of this chapter is to outline 
some of the crucial steps in developing a successful ECMO program including high-
lighting the necessary resources, team members and structure, and basic program 
structure and function.
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1. Introduction
Extra-corporeal membrane oxygenation (ECMO) or extra-corporeal life sup-
port (ECLS) is quickly becoming a well-established form of therapy for patients 
presenting in severe respiratory failure and/or cardiogenic shock. The fundamentals 
of therapy, while technically challenging and involving a complex dynamic human-
artificial circuit system, also requires a huge reliance on a multi-disciplinary team 
and an institutional infrastructure with robust administrative support at all levels to 
function effectively. While the medical and technical aspects of therapy are covered 
extensively in this text—and the others in this series [1, 2], a common fundamental 
question that is often asked is “how do we start and develop a program?” The devel-
opment of an ECMO/ECLS program is far more complex than organizing a small 
group of interested providers and acquiring the hardware necessary for support—as 
such, the goal of this chapter is to outline those steps necessary to help establish a 
foundation for a successful institutional program.
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2. Background
Acute respiratory failure—regardless of the etiology—remains a complex and diffi-
cult problem to treat. Management focuses on treating the primary problem and allow-
ing lung healing via lung protective ventilation strategies, while maintaining adequate 
oxygenation and ventilation [3]. Unfortunately, morbidity and mortality remain high 
in patients with severe lung injury, despite implementing standard lung protective 
strategies. Even for those patients who survive, quality of life can be severely impacted 
for many years after their initial illness [4]. Acute cardiac failure, or cardiogenic shock, 
also presents a difficult clinical problem for which even contemporary outcomes are 
less than ideal. While the most common cause of cardiogenic shock remains pump 
failure after an acute myocardial infarction, other mechanical problems such as acute 
papillary rupture (with acute mitral regurgitation), ventricular septal rupture, and 
myocarditis [5] must be considered [6]. While the use of ECMO for either acute respi-
ratory failure or cardiogenic shock (or often a combination of both) is well-described, 
in part due to more comprehensive reviews of these topics elsewhere in this text, their 
incidence and challenges—regardless of the circumstances—serve as a foundation for 
why there is a substantial interest in developing and growing ECMO programs.
There is growing evidence to support the role of ECMO in the management of 
these very difficult problems. ECMO has been shown to be an important tool in 
the armamentarium of any program that serves as a tertiary or referral center for 
complex cardio-pulmonary pathologies. In fact, excluding the survival benefit 
that has been demonstrated in patients who are supported with ECMO, there is 
also growing evidence to suggest that overall outcomes of patients with Adult 
Respiratory Distress Syndrome (ARDS) or cardiogenic shock treated at “ECMO 
Program Centers” are better regardless of whether they are treated with ECMO. In 
other words, the multi-disciplinary and administrative commitment to take care of 
patients (both adults and children) with complex and difficult cardiac and pul-
monary problems can lead to improved outcomes independent of the actual use of 
ECMO [7–10].
Two randomized clinical trials in patients with severe ARDS support the imple-
mentation and increased utilization of ECMO therapy [11, 12]. These randomized 
trials—again, topics that will be discussed elsewhere in this text—despite their 
controversies, have demonstrated a clinical benefit of ECMO in the setting of 
ARDS. These well-conducted randomized trials, in addition to the extensive body 
of literature (case series, single center reports, and Extracorporeal Life Support 
Organization (ELSO) registry reviews—far too numerous to reference) combined 
with growing society guidelines and position papers, serve as a solid foundation of 
medical science to support the development of ECMO programs worldwide [13].
3. Implementation process
The clinicians and administrators first determine the need and support for an 
ECMO program. This multidisciplinary group then operationalizes the care team 
that needs to be assembled and trained. The team includes clinical, administrative, 
ancillary, and other stakeholders, which are required to care for the patient and 
support the infrastructure, while moving the program to implementation.
3.1 Physician members
Physicians from Cardiothoracic Surgery, Pulmonary/Critical Care, and 
Cardiology form the foundation of physician support for veno-veno and 
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veno-arterial ECMO patient identification, insertion, and management. In addition 
to the core physician team, there is a need to engage neurologists and infectious 
disease specialists to understand the therapy and the unique patient care challenges 
and complications associated with ECMO support. Vascular surgeons often will get 
involved with cannulation if others are not available or comfortable with placing 
large bore cannulas—likewise, there is a growing interest by general and trauma 
surgeons [14].
In addition, the Palliative Care team must be involved from the very beginning 
of program’s development and some will advocate, especially in pediatric programs 
(while the focus of this chapter is on adult program development), Palliative Care 
providers are automatically involved and consulted on every ECMO case. As such, 
their understanding of the risks and benefits of ECMO are critical given the mar-
ginal outcomes associated with ECMO, even in the best of circumstances [15].
Inclusion of emergency physicians in the team can assist with early identifica-
tion of patients on presentation to the emergency room, and implementation of 
protocols in the emergency room for cardiogenic shock and respiratory failure [16].
3.2 Administrative stakeholders
Administrators from the executive team should be engaged early to help support 
the creation of structures to accelerate implementation, project management, and 
assurance of adequate capital and personnel resources for a sustainable program. 
Financial models, which obviously vary from system (and country) to system, 
must be considered—and given the amount of resources required to establish and 
maintain an ECMO program, it is wise to have someone to monitor the financial 
implications.
3.3 Ancillary services
Respiratory therapists assist with identifying possible candidates and work 
closely with the team ensuring the implementation of lung protective strategies. 
The growth of electronic medical records can allow for daily (if not more frequent) 
reports of those patients who might be considered for ECMO based upon ventilator 
settings and arterial blood case results.
Perfusionists must be engaged to help with setup, oversight of the ongoing treat-
ment and for their skill sets in understanding the complexities of the machines and 
testing required.
Finally, there are implications for laboratory department around testing and 
blood bank needs; as well as coordinating and consulting with case management, 
ethics, and chaplains in regard to complex shared decision-making to implement, 
care for, and remove therapy; and the rehabilitation needs for patients post-ECMO 
removal.
3.4 Nursing
In addition to leadership described previously, executive nursing leadership, 
departmental nursing leadership, nursing advanced practice providers (APP), 
and frontline nursing engagement are fundamental and are essential to assure the 
success of the program. This includes communication, input and collaboration 
with policy, procedures and evidence-based protocols, education and competency 
training of high performing clinical staff, and provision of surveillance and care of 
patients. Frontline nursing from outside the ICU are often engaged in patient flow 
and early identification of decompensating acute care patients, who may need to be 
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considered for ECLS. Since patients might require ECMO at any time, day or night, 
and given the amount of resources required to initiate and care for such patients, 
nursing administration must be involved to help develop protocols to organize 
“phone tree” lines of communication and specialized competent staff schedules to 
help recruit and arrange appropriate resources on very short notice.
3.5 Critical care transport
As the program grows beyond supporting the host hospital, it is necessary to 
engage Critical Care Transport to organize a system to transport patients from 
outside the facility with appropriate support and skill sets. This engagement is 
discussed more fully later in the chapter.
3.6 Nonclinical support
The IT department can help with order set development and the Medical Staff 
office will need to support the development of privileging requirements to assure 
consistent skill sets for new team members.
3.7 Establishing relationships with other tertiary centers
Especially in the situations with VA-ECMO use, long-term myocardial support 
may be needed. It is essential to build relationships with centers that can provide 
bridge to long-term LVAD support or transplant.
Additionally, the marketing and public relations departments engage to help 
in creating materials to help outlying hospitals and physicians have awareness of 
the program, with knowledge of how to identify patients and when to transport to 
higher levels of care for consideration of ECMO support.
4. Rapid change management
4.1 Triad leadership structure
A rapid pace for implementation is best served by a strong triad leadership: 
experienced physician leaders and champions who are experts in ECMO; nursing 
leadership; and hospital executives. All need experience in change management and 
are given support and authority to use project tools and cross-functional influence 
to fast track project goals across a wide span of departments. These members then 
must communicate progress within the executive team.
4.2 Change management approach
Following Kotter’s change management theory, a small group of physicians, nurs-
ing leadership, and administrators gather to set a vision, determine the feasibility 
and challenges of the project, then create a shared project plan for the organization, 
structure, and timeline for implementation of the program [17]. The creation of a 
Gantt chart with key requirements and milestones is helpful in the early stages of 
program development—also useful in a sense of accomplishment and motivation 
of the team. Regular recurrent frequent meetings with agendas driven by a project 
management tool to assure progress is made on key deadlines, accountability to the 
individuals and team, and to create a shared message and plan for continued commu-
nication. Initial work should focus on best practice, research-based literature review, 
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professional organization review of standards and data, then develop a gap analysis 
of clinical guidelines, equipment, skill sets, and organizational readiness. This small 
group should include Cardiothoracic surgeon(s), Pulmonologists, a “C” level execu-
tive, the cardiovascular service line, and Intensive Care nursing leadership. A small 
tactical group allows for more rapid progress through the initial stages and supports 
creation of a shared vision to accelerate momentum when the inevitable resistance 
to change surfaces—as well as working through team dynamics, comfort level, and 
building relationships. This group must strive to produce early wins, however small, 
to enable the organization to “feel the progress” as more difficult hurdles are faced. 
These can include shared clinical guidelines, order sets, and eventually patients that 
lived thanks to the program—as a true connect to purpose for all involved.
Putting screening guidelines in place and educating the teams on the benefits of 
ECMO to patients who would otherwise be terminal are very compelling when used 
in a story format.
Finally, change in management requires vigilance to newly implemented care pro-
cesses, or the tendency of the organization will slide back to previous status quo. Tools 
and strategies that assist in holding on to new skills are most effectively done through 
audits, constructive timely feedback, continuous process improvement discussions, 
and accountability to the process. While education can assist in reminding staff of the 
“why”, it is not a sticky tool in terms of cementing new behaviors into a culture.
Once the ECMO program is up and running, collaboration with the quality abstrac-
tionist and review of registry data at regular intervals generates quality improvement 
projects to assure new practice and clinical referral patterns producing the optimal out-
comes. It is also a way of preventing politics and rumors from gaining momentum as 
the facts are reviewed and discussed in larger quality forums. These forums are ideally 
multi-disciplinary and followed up with tangible action items that have due dates and 
closed-loop communication back to the CQI team, as the action items are completed.
5. Equipment
5.1 Hardware
The obvious hardware required for the program is the ECMO machine. The vari-
ables needed to make the correct choice for the program include need for portability 
of transport between facilities, as well as within the host organization, ease of use, 
skill sets of those responsible for managing the process, and the capital budget of 
the organization.
5.2 Disposables
In addition to the perfusion/ECMO machine, there is a need for a readily 
available stock of cannulas in various sizes, as well as for the variety of approaches 
that may need to be used. In addition, a well-stocked cart that allows the necessary 
equipment for sterile fields, cut-down, suturing, and possible complications of 
the cannulation procedures should be available to take to the patient’s location, as 
often the patient is not stable to transport to the OR for the procedure. As these are 
tools routinely used by perfusionists and cardiothoracic surgeons, they need to be 
engaged in selecting the appropriate sizes, manufacturers, connectors, introducers, 
wires and par levels. Many programs, as a function of the need to initiate ECMO 
therapy on short notice and in many different clinical areas, will create an “ECMO 
cart” which consist of all the key disposable equipment and tools needed to cannu-
late anywhere at any time (Table 1 and Figure 1).
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Supplies Size Ref # Qty
Cannulae:
Medtronic bio-medicus single stage venous 23Fr CB96605-023 ×1
21Fr CB96605-021 ×1
Medtronic bio-medicus multi-stage venous 25Fr 96880-025 ×1
21Fr 96880-021 ×1
Maquet avalon 31Fr 10031 ×1
27Fr 10027 ×1
Medtronic bio-medicus arterial 15Fr 96530-015 ×1
Medtronic bio-medicus nexgen arterial 17Fr 96570-117 ×1
19Fr 96570-119 ×1
21Fr 96570-121 ×1
Wires/dilators/introducer kits:
Medtronic arterial introducer kit 96552 ×1
Medtronic venous introducter kit 96551 ×1
Lunderquist extra stiff G31453 ×1
Amplatz super stiff M0066401080 ×1
Sorrin dilator kit ×1
4Fr micro puncture ×4
4Fr introducer ×1
6Fr introducer ×2
8Fr Introducer ×1
Packs:
Basic pack ×1
Angiography pack ×1
Suture:
Pledgets
2-0 Prolene SH ×4
2-0 Prolene MH ×4
3-0 Prolene SH ×4
3-0 Prolene RB-1 ×4
4-0 Prolene SH ×12
4-0 Prolene RB-1 ×12
4-0 Prolene large needle pledget ×12
4-0 Prolene small needle pledget ×12
5-0 Prolene C-1 ×4
6-0 Prolene BV-1 ×4
6-0 Prolene C-1 ×4
7-0 Prolene BV-1 ×4
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Supplies Size Ref # Qty
#1 Sofsilk ×6
0 Silk popoffs CT-1 ×4
1 Vicryl CTX ×2
0 Vicryl CTX ×2
0 Vicryl CT-1 ×2
2-0 Vicryl CT-1 ×4
3-0 Vicryl SH ×2
4-0 Vicryl PS-1 ×2
4-0 Monocryl PS-2 ×2
3-0 Ethibond SH ×6
Heavy silk ties ×4
2-0 Silk ties ×4
3-0 Silk ties ×4
4-0 Vicryl ties ×4
2-0 Ethicon pacing wires ×2
Orange pacing wires ×4
Blue pacing wires ×2
#6 Sternal wires ×2
Double wires ×2
Prep:
Chloraprep ×5
Duraprep ×1
Alcohol bottles ×2
PVP ×2
CHG surgical scrub brush ×5
Blades:
#10 ×10
#11 ×10
#15 ×10
Stryker sternal blade ×4
Hall redo blade ×2
Umbilical tapes ×8
Tourniquet 4 packs ×6
Red vessel loops ×2
White vessel loops ×4
Shods 10 pack ×2
Small yellow clip racks Qty 4 ×5
Small red clip racks Qty 4 ×5
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Supplies Size Ref # Qty
Small automatic clip applier ×1
Large automatic clip applier ×1
Asepto ×2
Suction tubing ×3
Cell Saver tubing ×2
Yankauer tip ×3
Poole tip ×2
Bovie pencil ×2
Bovie pad ×2
Long bovie tips
Short bovie tips
Eye cautery ×2
Snake clamp inserts ×1
86 mm inserts ×2
61 mm inserts ×2
33 mm inserts ×2
Hemostatics:
Bone wax ×6
Felt 4×4 ×1
Felt 6×6 ×1
GelFoam ×1
Fibrillar ×5
Snow ×2
Nu-Knit ×1
Laps ×9
Baby laps ×5
Raytec ×5
Gowns ×7
Towel packs ×4
Gloves
Drapes:
Split sheets ×2
3/4 Sheets ×6
Bi-Lat split sheet ×1
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Supplies Size Ref # Qty
Cardiac drape ×1
Tegaderms
4×4s ×5
Esmark ×1
Prineo ×1
Stapler ×1
Dermabond mini ×5
Hollister horizontal tube attachment device ×2
18 Ga Hypo ×4
Hep/blunt tip hypo ×4
60 cc syringe ×2
20 cc syringe ×2
10 cc syringe ×2
5 cc syringe ×2
Defib pads ×1
Pacing cables ×2
Decanters ×2
Plasmalyte 1 L ×2
Table 1. ECMO cart supplies (sample).
Figure 1. 
(a and b): Portable ECMO cart that contains all the disposable tools needed for initiating therapy.
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6. People
6.1 Structure and team building
The ECMO team skill set crosses a variety of normal reporting structures within 
the hospital, as well as contracted services used in hospitals, including surgical 
services, nursing, laboratory, perfusion, physicians—employed and independent. 
Hence, thought must be placed into creating a strong team-based culture among 
a group of individuals who may have primary team affiliation across multiple 
departments.
The use of multidisciplinary teams to develop project goals can serve as the 
first team building structure. Recognition of the team publicly can serve to bond 
the team more closely, and debriefings can prevent “silo formation” as individu-
als must often integrate in and out of the ECMO team due to patient volume and 
clinical needs. To cement this sense of team, the leaders of the departments that 
support the ECMO program should have regular meetings to discuss issues that 
arise, including productivity and interpersonal issues. Finally, the executive 
champion of the program should assure that there is accountability from all par-
ties to the success of the program through goals and metrics, periodic meetings of 
the entire group of stakeholders, and shared public recognition of the successes 
of the program.
6.2 Who watches the patients?
Early in the development of any ECMO program, there must be a strategy for 
establishing “who watches what”—specifically, while nursing will always have 
bedside management of the patient, there must be consideration given as who has 
dedicated responsibility for the ECMO pump and circuit. As with any technol-
ogy or “machine” that is directly connected to a patient—and provides critical 
life-saving support—there must be institutional guidelines and protocols regard-
ing who monitors the functional status of the pump and circuit assuring safe and 
continuous functionality. In addition, the specific roles and responsibilities of 
this individual also need to be clearly defined. Various staffing models exist as 
described below.
6.2.1 Perfusionist based
Perfusionist is ideal bedside ECMO care providers, while initiating an ECMO 
program. Their advantages are considerable experiences in managing patients 
requiring extra-corporeal support as a function of their primary job responsibilities 
in the operating room supporting cardiac surgery procedures. Their training, cre-
dentialing, and licensure will often include formal experiences in managing patients 
requiring short-term mechanical circulatory support, including ECMO, outside of 
the operating room environment. A perfusionist-based model is appealing, however 
there are resource and financial limitations of this model. Perfusionists are usually 
limited in number (especially if they are also supporting an active clinical cardio-
thoracic surgical program) and their perspective is from a different care model 
which is focused around staffing limited time intervals in the operating room rather 
than 24/7 ICU-based ECMO care management. They are also an expensive resource 
for 24/7 daily ECMO use in the ICU. Given their availability and cost (and depend-
ing on how a program “employs” perfusionists—salary, per diem, hourly, contract 
employees, etc.), other care models are preferred for providing bedside ECMO 
support, particularly for veno-veno ECMO patients.
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6.2.2 Nursing/respiratory therapy (RN/RT) based
RN/RT ECMO specialist staffing models are becoming widely accepted and 
utilized in programs nationally—these programs and the combination structure of 
RT and RN staffing pools are mainly volume dependent to maintain competence. 
RNs have many advantages with regards to their inherent familiarity with the com-
plexities and challenges in managing sick patients who require various life-support 
therapies. For example, in many programs, nurses manage renal replacement 
therapy technologies, wean and manage ventilators directly, and even have owner-
ship in the management of both short- and long-term cardiac/ventricular support 
therapies. An additional advantage is, as a function such nurses are often extremely 
experienced in the management and assessment of critically-ill patients, they can 
serve as a valuable resource in other areas of immediate patient care—and poten-
tially with volume and competence that become a primary care model for the more 
stable ECMO patient. Although respiratory therapists (RT) often have extensive 
experience in the management—and independent assessment—of patients requir-
ing mechanical ventilatory support, it has only been relatively recently that their 
experiences and training in pulmonary mechanics and respiratory physiology, have 
they as a profession, been engaged as ECMO specialists. In theory, since most busy 
intensive care units are often staffed with a high volume of RNs and RTs, who are 
clinically high performing and engaged, the addition of monitoring ECMO pumps 
and circuits might not require a substantial investment in human resources and 
expanding staffing models. As such, using RNs and RTs might be viewed as being 
potentially less expensive—it is important to recognize that prior to using this 
human resource to monitor ECMO patients, a substantial investment in extensive 
ongoing education and training to maintain competence is needed. There are many 
courses offered by large ECMO programs, professional societies, and ELSO (see 
below) that can assist in the training of bedside ECMO specialists. Significant 
advantages in the ECMO specialist staffing model, already described as financially 
fiscal, also include continuity of nursing-based care provided by hospital staff who 
have an investment in the organization and unit, as well as the patients they serve.
6.2.3 Hybrid models
Another attractive option is a combination of various specialists—often as a 
function of the acuity of the patient and the needs of the program at any given time. 
Such a model takes advantage of the strengths of each type of healthcare profes-
sional. Even though such models can be difficult to implement as protocols defining 
individual roles and when and how handoffs can occur, nevertheless, with a strong 
collaborative team, a hybrid model can be successful. For example, for “routine” (if 
such exists) veno-veno cases of isolated respiratory failure in an otherwise hemody-
namically stable patient, a perfusionist might help initiate therapy, provide the first 
24 hours of support, and once the patient is deemed stable on ECMO, care is handed 
off to a RT or RN ECMO specialist. On-call perfusion support for technical questions 
and issues can then be easily provided from home and might not require immediate 
bedside support. Veno-arterial cases, especially in post-cardiotomy patients, might 
be more complex, and therefore might require more direct involvement of perfu-
sionists given their experiences of managing such patients in the operating room. 
The challenge in a hybrid model is to determine either objectively or subjectively—
the clinical parameters that would allow for an appropriate hand-off between one 
type (or level) of provider to another (i.e. perfusionist to RN/RT ECMO Specialist).
Regardless of the care model provided, there must be collaboration between 
the team members to build evidence-based standardized protocols, as well as 
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strong physician buy-in in terms of supporting the individuals who manage the 
patient and pump at the bedside. Availability for immediate communication, 
using current technology, should be established between the ECMO specialist 
and/or perfusionist and the in-house physician. In addition, a strong and collab-
orative relationship between the ECMO specialist, perfusionist, and the bedside 
nurse must exist. Everyone must work together—inter-personality or profes-
sional conflicts cannot be tolerated and only get in the way of safe and effective 
patient care. Strong provider leadership, such as a perfusionist team leader, can be 
extremely effective in helping mentor other providers and serving as a resource 
for some of the day to day challenges in the management of an ECMO pump and 
circuit that might involve various disciplines, each of which have various levels of 
training and experiences.
In addition, while current ECMO pumps and circuits are much more reli-
able than previous technologies, they will often have more advanced monitoring 
options. Each specialist involved in the care of the patient must have extensive 
training and a sound understanding of the functionality and troubleshooting of the 
entire circuit. Simulation training, as discussed in other chapters, plays a critical 
role in education and maintaining proficiency and, therefore, should be a key 
component—when feasible—of every ECMO program.
7. Guidelines for therapy and patient selection
7.1 Access center/system
In a multiple hospital system of care, there is not generally a need for more than 
one ECMO center for the system to accommodate the needs for non-CT surgery-
related ECMO support. A helpful resource to assure patients have rapid transfer to 
the ECMO program from other hospitals, it is useful to set up a access center process 
to assure a standardized approach to hand-offs, transport, and tracking of patient 
movement. Call system personnel trained in the indications for ECMO can assist 
critical access and other facilities in routing possible ECMO patients for evaluation at 
the Center of Excellence. Early coordination with the call center leadership will allow 
them time to develop protocols, education, and coordination with transport services 
to assure smooth operations when the first patient call is received (Figure 2).
7.2 Where is ECMO initiated
A question that is often asked early in the development of any ECMO program 
is “where the patients should be cannulated?” While each institution must identify 
the ideal location for ideal cases, it is critical to recognize the nature of ECMO often 
dictates therapy must be able to be initiated anywhere within the hospital, includ-
ing, but not limited to the following locations:
• Emergency department
• Operating rooms (cardiac and non-cardiac)
• Catheterization labs
• Obstetric labor and delivery suites
• Intensive care units (medical, cardiac, surgical, neuro, etc.)
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In fact, depending on the resources available and the resilience of the team, 
some centers will often consider initiating therapy in unusual out-of-hospital loca-
tions with the extreme example being the recent initiation of ECMO in the Louvre 
Museum in Paris, France [18].
Prior to considering the ideal location for initiating therapy, it is critical to 
outline those technologies that might be required. As discussed above, while it is 
important to have an “ECMO Cart” that contains, in a single location, all the key 
disposables that might be required, there might be a need for less portable equip-
ment. For example, for cannulation, physicians might need immediate access to 
fluoroscopy and/or transesophageal echocardiography. Such technology might only 
be readily available in an operating room or catheterization lab. As many operating 
rooms, especially major trauma centers, and cardiac catheterization laboratories 
that support STEMI programs will often have access to advanced imaging, the 
exact ideal location often is dictated not only by physician preference, but also by 
potential administrative considerations. Such administrative considerations include 
the availability of a team to support cannulation, how disruptive emergency ECMO 
Figure 2. 
Patient access/call center flow.
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cases would be to the scheduling and allocation of OR/Cath lab resources, and often 
“how comfortable” the team is with the procedures. For example, Cath lab teams 
who are more comfortable with the catheter and wire-base procedures than surgi-
cal team might be a better option for peripheral cannulation of ECMO (arterial 
and venous)—while operating room teams might be better skilled at assisting with 
central cannulation (especially if the chest is already open). Nevertheless, a core 
“ECMO team” of providers beyond physicians and perfusions must be identified 
and included in all communications so that therapy can be initiated efficiently and 
safely anywhere needed.
7.3 Order sets
Order sets provide a rapid, standardized, initiation for ECMO. The order set 
should include guidance for the perfusion team and nursing team to appropriately 
care for the patient in a variety of settings, as well as give parameters for physician 
notification to address changes in patient status quickly.
Order set elements should include:
• Instructions for ECMO machine priming
• ECMO circuit settings
• ECMO daily parameters
• Instructions for the perfusionist/nurse in charge of the machine
• Instructions to leave all catheters in if not functioning and notify physician
• Ventilatory settings
• Blood products and transfusion parameters
• Massive transfusion protocol parameters
• Post-cannulation radiology studies
 ◦ AP abdomen post-cannulation
 ◦ AP chest post-cannulation
• Radiology ◦studies
 ◦ Echocardiogram for symptoms
 ◦ Daily and routine laboratory studies
• Anticoagulation and associated laboratory monitoring and adjustments
• Triggers for notification of the ECMO physician/nurse practitioner
• Other
 ◦ Nursing care
 ◦ Sedation medications
15
Clinical and Administrative Steps to the ECMO Program Development
DOI: http://dx.doi.org/10.5772/intechopen.84838
• Physical therapy
 ◦ Occupational therapy
 ◦ Case management
 ◦ Routine ICU parameters
8. ECMO transports
Critically ill patients requiring ECMO can be transported by ground, helicopter, 
and fixed wing aircraft. Considerations in choice of transport include distance, 
number of team members required, equipment, electrical and oxygen needs, and cost. 
Ideally, patients can be identified and transported prior to initiation of ECMO therapy, 
however there are models of care with good results in which the team goes to the 
patient and initiates ECMO, and then the patient is transported to the ECMO center.
8.1 Team members for transport
Per the 2015 ELSO guidelines, team members will vary depending on the need to 
cannulate the patient [19]. An ECMO specialist physician is required in either case, as is 
an ECMO specialist and a transport RN/RT. If cannulation is required, and the ECMO 
specialist physician is unable to perform this, there may be the need to add a cannulat-
ing physician and a surgical assistant to the team. Each team member has specific roles 
that should be delineated and understood prior to deployment to the outlying facility.
A checklist, should include all the needed equipment for the return trip with the 
patient, and should be verified prior to departure.
The equipment recommended by ELSO includes [20]:
1. Suitable blood pump, centrifugal, or roller
2. Membrane oxygenator, appropriate for the patient size
3. Device(s) for heating and regulating circuit blood temperature (less critical for 
adult transports)
4. Medical gas tanks, regulators, hoses, connectors, flow meters, and blenders for 
provision and adjustment of blended sweep gas to the oxygenator
5. Venous and arterial pressure monitoring device(s), according to center-
specific practices
6. Point-of-care anticoagulation monitoring equipment (e.g., activated clotting time)
7. Emergency pump or manual control mechanism in the event of primary pump 
failure or power failure
8. Uninterruptible power source(s) capable of meeting the electrical power needs 
of all equipment during transfer between vehicles and in the event of vehicle 
power source failure.
9. Portable ultrasound machine, if not provided by the referring facility
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Additional equipment recommended by 2015 ELSO to improve safety includes:
1. System for servo-regulation of flow to balance venous drainage rate from the 
patient and blood return to the patient
2. Blood flow rate monitor (may be internal or external to the blood circuit)
3. Monitor(s) for circuit blood temperature, blood gas, oxygen saturation, and 
hemoglobin (may be internal or external to the blood circuit)
4. Capacitance “bladder” incorporated into the circuit
5. Bubble detector with or without automatic pump regulation function
Of note, the requirements for voltage, current, and power for all equipment 
should be verified for the transport vehicle prior to departure and monitored 
throughout transport. An adequate oxygen source must also be available with 
sufficient reserve to support high-flow 100% oxygen delivery for the duration of 
the transport. Provisions must be made to adequately secure the equipment dur-
ing transport—brackets, holders, straps, etc. should be tested prior to first-time 
transport and should be compliance with appropriate regulatory guidelines (i.e., 
Federal Aviation Administration for the United States) (Table 2).
No patient should be transported without a means of manually providing circuit 
flow in the event of an electrical pump failure or malfunction.
9. Quality and outcomes
As with all areas of medicine, the optimization of patient outcomes must be 
a priority. This concept is especially important in the context of developing and 
maintaining an ECMO/ECLS program. Many other disease therapies have an 
infrastructure for monitoring clinical outcomes and benchmarking them against 
peer groups, national, and even international programs. These infrastructures 
typically are in the form of voluntary registries and databases (although some might 
argue that participation is becoming less and less voluntary and more and more a 
Method of 
transport
Advantages Disadvantages Distance for 
transport
Ground 1. Lowest cost
2. Least noise
3. Number of team embers
4. Ease of loading equipment
5. Unlimited weight
1. Shortest ideal distance for 
transport
Up to 300 miles
Helicopter 1. Speed
2. Ease of loading equipment
3. Limited weight
1. Least number of team 
members
2. Noise
3. Higher cost
Up to 450 miles
Fixed wing 1. Speed
2. Number of team members
3. Limited weight
1. Costly
2. Can be difficult to load 
equipment
3. Noise
Unlimited
Table 2. 
Decision-making for ECMO transport options.
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requirement—especially are payor sources are starting link payments to participa-
tion and eventually outcomes in such programs). Examples of these types of pro-
grams include the Society for Thoracic Surgeons (STS) Outcomes database (https://
www.sts.org/registries-research-center/sts-national-database) and the American 
College of Cardiology National Cardiovascular Data Registry (ACC NCDR: https://
cvquality.acc.org/NCDR-Home). Both organizations also for submission of patient 
characteristic data, comorbidities, therapies performed, and outcomes with the goal 
of providing program (and sometimes provider) specific outcome data—often risk 
adjusted, therapy specific, and benchmarked against other programs with provided 
summaries that can allow for continuous quality improvement initiatives.
9.1 Role of ELSO
Currently, the Extracorporeal Life Support Organization (ELSO) provides 
a mechanism for tracking and benchmarking outcomes for ECMO programs 
(https://www.elso.org/Home.aspx). The organization was founded in 1989 and is 
headquartered in Ann Arbor, Michigan, USA. While the organization serves many 
roles to assist ECMO providers and programs—voluntary membership allows for 
the submission of clinical program outcome data and in return, summary data are 
provided. The organization also provides access to clinical guidelines, discussion 
forums, announcements for relevant meetings, links to key publications and refer-
ences, and overall serves as a hub for ECMO/ECLS-related activities. Membership 
is strongly encouraged and the organization claims international membership and 
helps coordinate worldwide activities.
9.2 Interval reviews
In addition to submitting clinical patient and outcome data for benchmarking 
to ELSO, programs should also establish a formal case presentation and review 
process. Much like traditional surgical “morbidity and mortality” reviews, 
given the high-acuity and resource intensive nature of ECMO, similar periodic 
reviews of institutional ECMO outcomes should also be reviewed. While the 
focus should not be in individual practices or decision-making, ideally, each 
case should be reviewed by the team in a non-judgmental fashion to explore for 
potential areas of opportunity. Likewise, while good outcomes should be discus-
sion in the context of “what went right”—such cases should also serve as team 
learning opportunity for growth and improvement. Depending on the number 
of cases performed, such meetings should be held in a timely manner (monthly, 
quarterly, etc.) so that real-time assessments can be performed and the nuances 
of each case might still be relatively fresh in the minds of the providers. While 
the structure of such meetings can be variable, many “quality” meetings typi-
cally will only involve key stakeholders—both providers (i.e. physicians, ECMO 
specialists, perfusionists, etc.) and appropriate administrators. The benefit of 
having meetings limited is that there is then the opportunity for open, honest, 
and transparent conversations—either on a case-by-case basis or from a pro-
grammatic standpoint—in a manner that can and should be protected from legal 
disclosure under the umbrella of a formal peer-review or quality improvement 
initiative. Appropriate protections of patient data and provider involvement 
must be maintained and established from the onset.
Likewise, summary data of program outcomes—such as the number of cases, 
types of cases, and overall outcomes should be actively tracked in real-time and 
made available to institutional leadership as a gauge of program growth and success. 
Institutional leadership/administration should also be able to provide financial data 
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as profit/loss margins must be tracked in the context of program growth and suc-
cess. Additional benchmarking information should also be considered and tracked 
in real-time to help monitor the evolution of a program—and should include, but 
not necessarily be limited to:
(1) Patient demographics (i.e., age, gender, and major comorbidities)
(2)  Primary indications for support and etiologies of respiratory failure and/or 
cardiogenic shock
(3) Type of support (VV, VA, eCPR, and cannulation)
(4) Duration of support
(5) Blood and blood product utilization
(6) Outcomes
• Successful weaning from support
• Death on support
• Death despite successful weaning
• Major factors contributing to patient death (i.e., multi-organ failure,  
neurologic, etc.)
Such summary data should be in addition to the extensive amount of clinical and 
circuit data that is collected and tracked in the ELSO registry (see above).
9.3 Continuous quality improvement (CQI)
As discussed above, the tracking of outcome data should be a key component to 
helping measure program growth and success. Such initiatives must be established 
from the onset and involve the program champions—both clinical and administra-
tive leaders to be successful. While it is important to review cases in the context of 
Topics for review Potential desired outcome
Anticoagulation protocol Reduction in bleeding and bleeding related 
complication.
Reduction in blood product utilization
Antibiotic utilization Integration in an antibiotic stewardship program
Reduction in multi-drug resistant infections
Reduction in opportunistic infections
Time from admission/intubation to initiation of 
ECMO support
Potential impact on improving weaning and survival 
outcomes
Mortality despite successful weaning from 
ECMO
Improving overall outcomes and survival to discharge.
Medication utilization Opportunities for potential cost savings
Family/patient satisfaction scores Opportunities to improve communication with families, 
Improved satisfaction metrics
Table 3. 
Suggested topics for continuous quality initiatives
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tracking outcomes—both good and bad—from a programmatic standpoint, it is also 
important to examine outcome summary data with the focus of exploring potential 
opportunity for improvement. It should be a primary objective of the ECMO team 
to consider periodic continuous quality improvement (CQI) activities. The activities 
should be viewed as opportunities to review best practices, current literature on vari-
ous topics, and metrics with the focused goal of improving outcome metrics—while 
the primary focus should always be on improving patient survival, other metrics, 
program practices, and guidelines should also be considered as topics for review. Key 
topics can be identified, champions identified, and a timeline established for review 
and the development of potential action plans. While the specific details of how to 
develop and implement CQI is out of the scope of this topic—it does emphasize the 
importance of engaged administrative leadership individuals and team who have 
established experiences with these programmatic and institutional activities. By no 
means, comprehensive, various CQI topics are listed in Table 3.
10. Miscellaneous topics
10.1 Referral sources engagement
Once the complex set of internal processes, personnel, and patient care skills are 
established, the ECMO program has the potential to serve patients in a wide area 
around the ECMO center. To assure that other hospitals and emergency facilities 
have the information to know of the resources available, and when to engage them, 
the primary facility should engage a multi-pronged approach to raise awareness 
and clinical decision-making skills of potential patient care partners. As with all 
endeavors, this should be done in the WIIFM (What’s In It For Me) with the patient 
and practitioner at the outlying facilities interests’ in mind. A good place to begin 
this is to address the benefits to the patient, the current science that supports the 
need for ECMO, the parameters for consideration of ECMO support, the process to 
easily move the patient, and the resources to enhance education of the topic. This is 
accomplished by marketing informational materials, individual outreach to create 
awareness, an education program that includes lectures, publication of successes, a 
plan for follow-up communication to the referring institution to help them under-
stand the results of their referrals, and finally, by creating branding that helps the 
referral sources easily retain a connection to the program.
10.2 Marketing
Marketing materials should ideally be created to reflect the ECMO program as 
a larger system of care around ARDS and shock. In addition to the organization 
housing the ECMO program, clear guidance on referral processes (see Call Center 
Section), there should also be some succinct explanation of the use of VV and VA 
ECMO, parameters for initiation of referral, as well as references to studies support-
ing the decision. Consideration should be given to having two sets of guidance; one 
for critical access lower acuity facilities/ER’s and one geared toward facilities with 
ICU care directed by intensivists, as the threshold for referral will be different.
10.3 Outreach
The personal touch of a visit cannot be underestimated when establishing trusted 
referral center status for complex procedures such as ECMO. It affords a chance to 
create personal trust, as well as allowing answers to questions are procedures and 
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processes for transfer, and expectations for communication regarding patient status 
from the ECMO center. The outreach should be well versed on all of these processes, 
as well as having the ability to provide physician to physician conversations to 
answer any outstanding issues.
10.4 Education
Education is a valued commodity for referring physicians and clinicians when 
learning a new resource for their patients. The education can include multiple for-
mats to meet the needs of the audience including lectures, educational brochures, 
webcasts, publications regarding outcomes and patient stories, and conferences 
at the ECMO center on topics related to ECMO such as current ARDS and shock 
therapies.
10.5 Follow-up communication
While clearly an avenue to enhance education, follow-up communication is 
also an important tool to create the interpersonal relationship that develops trust 
between the organizations. It is very important for referring provider to learn the 
“end of the story” regarding patients that were sent for therapy. In addition, this 
provides a transition of care so that appropriate ongoing care can be provided to 
the patient in their home medical community. This also establishes that trust of the 
referring providers that patients sent for a specific therapy will be sent back to the 
home community for the care that can be provided in that setting.
10.6 Branding
As the use of ECMO increases, the need to create a memorable brand for the 
program becomes a key component to establishing the reputation of the ECMO 
center that is distinguishable from other future programs. The program should 
ideally be branded as a part of the larger cardiothoracic-vascular/pulmonary/
critical care program of the institution. This allows the halo of the organiza-
tion’s programs to create synergistic enhancement quality outcomes and growth 
opportunities.
11. Conclusions
The initiation of an ECMO program is a comprehensive multidisciplinary 
project, which must be based on the clinical needs of the patients served. It requires 
advanced clinical capabilities and decision-making, and clear pathways for patient 
care to make it high quality and financially sustainable. As such, strong leadership is 
needed from physician leaders, nursing leaders, and administrative leaders working 
in a triad professional leadership model.
Once the clinical case for implementation is made, a multidisciplinary team 
should be identified, and given the ability to work across multiple departments and 
stakeholders to assure all quality and operational details are aligned and accom-
plished. The team is encouraged to work using change management format and 
techniques supported with strong project guidelines to assure that the internal and 
external resources needed to support ECMO care are identified, captured as project 
goals, and systematically completed prior to initiation of ECMO patient care. Use of 
tools such as order sets, access center protocols, and education tools support clinical 
standardization across the team, and provides a consistency of clinical care.
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Quality metrics are identified at project initiation and can be supported by ELSO 
tools allowing comparisons across programs internationally. The commitment to high 
quality and a relentless curiosity to find improvements that can be made, are critical to 
provide best practices to this high acuity population. The data and outcomes collected 
can help educate and encourage referrals from other programs that do not have ECMO 
capabilities, thus providing added advanced patient care options on regional basis.
The literature has previously benchmarked an 18 month ramp up to program initia-
tion as rapid deployment. Using the tools provided by others in the literature, a strong 
triad leadership process, and a dedicated multidisciplinary team with strong project 
management support, it is possible to accomplish program initiation in a six-month 
period in a hospital with an established CV Surgical program. We believe this process 
is replicable, and provides tools and implementation models that can be used by other 
hospitals to add needed ECMO support to meet their community needs [8–10].
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